Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akuffo

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Immunology|March 20, 2004
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donorsS Nylén, K Maasho, D McMahon-Pratt, et al.
Infection and Immunity|March 1, 1987
Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clonesS Hussein, J Curtis, H Akuffo, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1995
In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testingH Akuffo, M Darce, K Maasho, et al.
Medical Microbiology and Immunology|January 5, 2002
Emerging Leishmania/HIV co-infection in AfricaD Wolday, N Berhe, H Akuffo, et al.
Scandinavian Journal of Infectious Diseases|July 22, 1998
Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cellsD Wolday, H Akuffo, G Fessahaye, et al.
Clinical and Experimental Immunology|February 28, 2003
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gammaS Nylén, K Maasho, K Söderstrom, et al.
Clinical and Experimental Immunology|February 26, 2005
Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in miceD Elias, H Akuffo, C Thors, et al.
Scandinavian Journal of Immunology|December 1, 1987
Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differencesH Akuffo, E Schurr, G Andersson, et al.
International Journal of Molecular Medicine|December 16, 1998
Drosophila antibacterial protein, cecropin A, differentially affects non-bacterial organisms such as Leishmania in a manner different from other amphipathic peptidesH Akuffo, D Hultmark, A Engstöm, et al.
Scandinavian Journal of Immunology|April 1, 1994
HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alphaD Wolday, H Akuffo, S Britton, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Immunology|March 20, 2004
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donorsS Nylén, K Maasho, D McMahon-Pratt, et al.
Infection and Immunity|March 1, 1987
Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clonesS Hussein, J Curtis, H Akuffo, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1995
In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testingH Akuffo, M Darce, K Maasho, et al.
Medical Microbiology and Immunology|January 5, 2002
Emerging Leishmania/HIV co-infection in AfricaD Wolday, N Berhe, H Akuffo, et al.
Scandinavian Journal of Infectious Diseases|July 22, 1998
Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cellsD Wolday, H Akuffo, G Fessahaye, et al.
Clinical and Experimental Immunology|February 28, 2003
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gammaS Nylén, K Maasho, K Söderstrom, et al.
Clinical and Experimental Immunology|February 26, 2005
Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in miceD Elias, H Akuffo, C Thors, et al.
Scandinavian Journal of Immunology|December 1, 1987
Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differencesH Akuffo, E Schurr, G Andersson, et al.
International Journal of Molecular Medicine|December 16, 1998
Drosophila antibacterial protein, cecropin A, differentially affects non-bacterial organisms such as Leishmania in a manner different from other amphipathic peptidesH Akuffo, D Hultmark, A Engstöm, et al.
Scandinavian Journal of Immunology|April 1, 1994
HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alphaD Wolday, H Akuffo, S Britton, et al.
Pageof 4